Stay updated on Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator has been updated from v3.5.0 to v3.5.3, reflecting an incremental website build change rather than an update to the underlying study record details.
    Difference
    0.0%
    Check dated 2026-04-26T15:28:58.000Z thumbnail image
  4. Check
    52 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T19:59:31.000Z thumbnail image
  5. Check
    66 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T04:30:15.000Z thumbnail image
  6. Check
    88 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:28:03.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.1, replacing v3.4.0, with no changes to study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:15:16.000Z thumbnail image
  8. Check
    117 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-15T04:43:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page.